Company Immunotech Laboratories, Inc. Other OTC

Equities

IMMB

US45254F2039

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Bio Therapeutic Drugs

Inactive Instrument

Immunotech Laboratories, Inc. (Immunotech) is a drug development company that focuses on research and development in the biotechnology field. The Company is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.

USD in Million	2016	Weight	Delta
Proprietary Proteins nan %	0	nan %	-

USD in Million	2016	Weight	Delta
United States nan %	0	nan %	-

Managers	Title	Age	Since
Harry Zhabilov CHM	Chairman	57	30/11/07

Members of the board	Title	Age	Since
Harry Zhabilov CHM	Chairman	57	30/11/07
Valentin Dimitrov BRD	Director/Board Member	59	03/02/13

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	574,964,967	58,100,000 ( 10.10 %)	0	10.10 %
Stock B	0	4,000,000	0	0

Immunotech Laboratories, Inc.

120 West Pomona Avenue

91016, Monrovia

address Immunotech Laboratories, Inc.(IMMB)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+0.93%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.03%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.73B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B

Bio Therapeutic Drugs